
Taurus™ Platform for difficult targets Antibody Discovery
GeneMedi’s Taurus™-Antibody Discovery Platform is to achieve Tough Antigen Unique-epitope Recognized with Unique Smart-immunogen strategy.
1) Smart-design immunogens for difficult-target antibody discovery
2) Data-driven immunogen-specific antibody discovery with unique-HTS strategy
3) Structure-based epitope computation for unique-epitope functional antibody discovery
Case study
Antibody discovery for multi-pass transmembrane protein
It is difficult to generate multi-pass Transmembrane protein(TP) immunogen with natural structure. Besides, multi-pass TP shows lower specificity since high homology of extracellular structure, especially for some homologous gene family.

- GENEMEDI
- 6th Floor, Building No.2, Kangxin Road 3377, Shanghai, China
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]


<